ArticleBMC oral health2025
Long-term upper airway changes following mandibular advancement with or without maxillary setback in skeletal class II patients: a 2-year retrospective study.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThis study assessed 2-year oropharyngeal airway changes in skeletal Class II patients following isolated mandibular advancement by bilateral sagittal split osteotomy (BSSO) with or without maxillary setback by Le Fort I osteotomy (Le fort I). MATERIALS AND
methodsCone-beam computed tomography (CBCT) data from 25 isolated BSSO and 57 BSSO + Le fort I patients were retrospectively analyzed at three stages: preoperatively (T0), 3 months (T1), and 2 years postoperatively (T2). The total upper airway volume (V), minimum cross-sectional area (CSA
resultsIsolated BSSO significantly increased V, CSA
conclusionIsolated BSSO induces sustained upper airway expansion for 2 years, which is driven primarily by hard tissue advancements. Compared with BSSO + Le fort I, this technique has superior short- and long-term efficacy, providing guidance for the optimized management of skeletal Class II patients. ETHICS APPROVAL: This study was approved by the Ethics Committee of Peking University Stomatological Hospital (Approval No. PKUSSIRB-202167121).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.